Compare COLL & SPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COLL | SPH |
|---|---|---|
| Founded | 2002 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2015 | 1996 |
| Metric | COLL | SPH |
|---|---|---|
| Price | $45.76 | $20.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $51.17 | N/A |
| AVG Volume (30 Days) | ★ 406.2K | 163.8K |
| Earning Date | 02-26-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 6.42% |
| EPS Growth | N/A | ★ 89.48 |
| EPS | 1.63 | ★ 2.01 |
| Revenue | $757,067,000.00 | ★ $1,429,575,000.00 |
| Revenue This Year | $26.17 | $2.06 |
| Revenue Next Year | $3.65 | $1.64 |
| P/E Ratio | $28.17 | ★ $10.08 |
| Revenue Growth | ★ 26.34 | 7.11 |
| 52 Week Low | $23.23 | $17.30 |
| 52 Week High | $50.79 | $22.24 |
| Indicator | COLL | SPH |
|---|---|---|
| Relative Strength Index (RSI) | 46.77 | 62.53 |
| Support Level | $43.99 | $19.83 |
| Resistance Level | $49.31 | $20.24 |
| Average True Range (ATR) | 1.62 | 0.50 |
| MACD | -0.12 | -0.03 |
| Stochastic Oscillator | 38.19 | 73.44 |
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
Suburban Propane Partners LP distributes propane, renewable propane, renewable natural gas (RNG), fuel oil, refined fuels, and markets natural gas and electricity in deregulated markets. It produces and invests in low-carbon fuel alternatives. The company installs and services home comfort heating and ventilation equipment and distributes fuel oil, kerosene, diesel, and gasoline to about 25,000 residential and commercial customers mainly in the U.S. northeast. It operates three segments: Propane, Fuel Oil and Refined Fuels, and Natural Gas and Electricity, with the Propane segment generating the majority of revenue. Propane, a by-product of natural gas processing and petroleum refining, is a clean-burning energy source known for transportability and ease of use.